Clinical trial NCT05185063: Developing a Digital Handover Application for Paramedics to Provide a Personalized Approach to Pre-hospital Stratification for Out of Hospital Cardiac Arrest
Official title: Developing a Digital Handover Application for Paramedics to Provide a Personalized Approach to Pre-hospital Stratification for Out of Hospital Cardiac Arrest
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Out of Hospital Cardiac Arrest
Lead sponsor: King's College London
Sponsor class: OTHER
Collaborators: name: London Ambulance Service NHS Trust
name: King's College Hospital NHS Trust
First posted: 2022-01-11
Enrollment: 500
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Community (i.e. pre-hospital study)

Brief summary: A prospective study validating the role of the MIRACLE2 score in patients with resuscitated out of hospital cardiac arrest in a pre-hospital setting.

Detailed description: Design: Prospective observational cohort study enrolling OOHCA patients across London in a pre-hospital setting

Study Protocol: Patients with OOHCA and ROSC will be recruited from the community into the study by London Ambulance Service NHS Trust (LAS). LAS has -40 Advanced Paramedic Practitioners in Critical Care (APP-CC) who have a range of specialist skills including airway management and focused ultrasound and attend to over 1500 OOHCAs/year.

Point of Care pH test: The recruited participants will have point of care pH testing performed using the CG4+ iStat system (Abbott Vascular, Illinois, U.S.A.). The test requires 2ml of venous blood and can provide blood results within minutes. The device and blood taking system have received CE marking and are already in routine use across the NHS. Once the blood results are received, the blood sample and testing system are discarded in a routine manner.

Standard Care: Participants will then be conveyed to either the local emergency department or to a HAC based on current routine protocols. Patients will be treated in a routine manner after reaching secondary care in accordance with local and national guidance with no change in care based on this study.

Power calculation: In 2019, APP-CCs from LAS attended to -700 OOHCA patients with ROSC. Assuming 60% recruitment, we could comfortably envisage -500 patients to be recruited in a 15 month period. From previous data, we can expect approximately 60% of the patients (n=300) to have a CPC score of 3-5 on hospital discharge. This would be of a similar size to the dataset used to derive the original score, which gave good levels of accuracy in model performance measures.

Eligibility criteria: Inclusion Criteria:

* Patients with out of hospital cardiac arrest with sustained ROSC (defined as \>20 minutes or sufficient stability to consider conveyance)

Exclusion Criteria:

* Any clear non-cardiac cause of arrest (trauma, drowning Overdose, asphyxia, asthma, anaphylaxis).
* Suspected or confirmed intra-cerebral bleeding
* Known CPC score 3 or 4 pre-cardiac arrest
* Known disease limiting survival to 6 months
* Suspected or known pregnancy

Primary outcomes:
measure: Cerebral Performance Category at 30 days
timeFrame: 40 dats
Secondary outcomes:
measure: All cause mortality at 30 days
timeFrame: 30 days
measure: Cause of Death at 30 days
timeFrame: 30 days
measure: Cerebral Performance Category at 6 months
timeFrame: 6 months
measure: All cause mortality at 6 months
timeFrame: 6 months
measure: Cause of Death at 6 months
timeFrame: 6 months
Other outcomes:
Locations:
Study officials:
affiliation: King's College London
name: Nilesh Pareek, MA,MRCP,PhD
role: PRINCIPAL_INVESTIGATOR
References: